← Return to Has anyone used the Marodyne device to stimulate bone growth?

Discussion
Comment receiving replies
@baguette

The FDA has just approved a wearable vibration device called Osteoboost.

From the press release of Jan. 18, 2024:" Osteoboost is a wearable belt device, worn on the hips, that delivers targeted, calibrated vibration to the lumbar spine and hips. Osteoboost is indicated to reduce bone strength and density decline in postmenopausal women and is the first and only solution specifically designed to improve bone health during osteopenia. This breakthrough technology is safe, medication-free, and easy to use at home, making it suitable for a wide variety of patients with bone density loss. "
https://www.bonehealthtech.com/page/news/
I was puzzled/disappointed that the manufacturer referred to osteopenia and not osteoporosis too. Don't know if it wasn't tested on those with osteoporosis, or if it was tested on those with osteoporosis and didn't perform well. If anyone knows that answer please share!

Jump to this post


Replies to "The FDA has just approved a wearable vibration device called Osteoboost. From the press release of..."

I have been asking this question too but so far haven’t received any responses. I have tried writing the company too. I will see if I can find another address. BTW, I think you have to get a prescription to get this. Oh, I just read this on their website:
“ This device is not indicated for patients with osteoporosis.”
And also, anyone with a fracture or t-score less than -2.49 (& a bunch of other conditions) was excluded from the study.
https://www.bonehealthtech.com/indications-for-use/

It's hard to get good clear info on their study. It does not look like they have published the results of their "Spry Belt Study". You can see the study design here: https://clinicaltrials.gov/study/NCT03986203?tab=table. It looks like they presented data from the study at a couple of conferences. "BHT presented data from their clinical trial at ASBMR 2023 and ENDO 2023".
In a blog post on their website they say this "The primary goal of the study was to provide quantifiable measurement in the change in vertebral strength using Biomechanical Computed Tomography and finite element analysis. The participants in the Active Treatment group who used the device a minimum of 3 times per week throughout the year experienced an average bone strength loss of 0.48%. In contrast, those in the Sham group lost 2.84% on average, indicating a relative difference of 2.36% (P=0.014). This represents an impressive 82% reduction in the rate of bone strength loss among the Active Treatment group."
So much less bone strength loss but not a gain. I couldn't find DXA score data.

As to osteopenia vs osteoporosis, I suspect this was a financial - marketing - FDA approval type of decision to shoot for the osteopenia market. Probably not a scientific one where there is some reason it works for osteopenia and not osteoporosis. That's just my guess. I'm not sure what to think of this device at this point.